Congress trades
Repligen Corporation (RGEN)
About Repligen Corporation
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Olivier Loeillot
- Employees
- 2,000
- Listed since
- Apr 29, 1986
- Market value
- $9.3B
- Price to earnings
- 223.0
- Earnings per share
- $0.74
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 3, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 28, 2026 | $0.54 | $0.45 | $204.1M | $201.6M | EPS beatRevenue in line |
| Q1 FY2026reported May 5, 2026 | $0.48 | $0.38 | $194.3M | $192.1M | EPS beatRevenue in line |
| Q4 FY2025reported Feb 24, 2026 | $0.49 | $0.44 | $197.9M | $192.9M | EPS beatRevenue beat |
| Q3 FY2025reported Oct 28, 2025 | $0.46 | $0.42 | $188.8M | $182.1M | EPS beatRevenue beat |
| Q2 FY2025reported Jul 29, 2025 | $0.37 | $0.40 | $182.4M | $175.2M | EPS missRevenue beat |
| Q1 FY2025reported Apr 29, 2025 | $0.39 | $0.35 | $169.2M | $163.7M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 2, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Olivier LoeillotPresident and Chief Executive Officer | $860K | $3.4M | $1.9M | $6.1M |
| Jason K. GarlandChief Financial Officer | $567K | $1.5M | $922K | $3.0M |
| James BylundChief Operating Officer | $481K | $1.6M | $862K | $2.9M |
| Ralf KuriyelSenior Vice President, Research and Development | $421K | $1.2M | $694K | $2.3M |
| Brian DouglassSenior Vice President, Chief Product Officer | $417K | $912K | $405K | $1.7M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $734.7M | 5,384,938 | -10.1% | 9.55% |
| FMR LLC | $453.9M | 3,326,690 | +15.2% | 5.90% |
| United Capital Financial Advisers, LLC | $380.8M | 2,790,650 | +0.6% | 4.95% |
| Vanguard Capital Management LLC | $329.0M | 2,411,171 | +0.6% | 4.28% |
| Vanguard Portfolio Management LLC | $315.6M | 2,312,825 | +0.3% | 4.10% |
| Maverick Capital Ltd | $270.8M | 1,984,554 | +30.7% | 3.52% |
| State Street Corp | $245.7M | 1,800,530 | +1.3% | 3.19% |
| Price T Rowe Associates Inc | $239.1M | 1,752,274 | -64.1% | 3.11% |
| Massachusetts Financial Services Co | $220.6M | 1,617,021 | +15.7% | 2.87% |
| Wasatch Advisors LP | $217.0M | 1,590,251 | +27.9% | 2.82% |
| Ameriprise Financial Inc | $215.0M | 1,576,132 | +70.4% | 2.80% |
| Bank Of New York Mellon Corp | $207.8M | 1,522,859 | -0.6% | 2.70% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in RGEN
8 disclosures of 8 on record · median 22d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +15.9%S&P +12.3% · vs S&P 500 +3.6% | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +12.4%S&P +12.0% · vs S&P 500 +0.5% | Oct 31, 2025 | Nov 21, 2025 | 21d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +15.9%S&P +13.2% · vs S&P 500 +2.7% | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +27.0%S&P +27.0% · vs S&P 500 0.0% | Jun 11, 2025 | Aug 13, 2025 | 63d |
| Lisa C. McClainSpouseFiled late | Stock | Sale | $1,001 - $15,000 | +38.5%S&P +27.8% · vs S&P 500 +10.7% | Jun 17, 2025 | Aug 13, 2025 | 57d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +46.9%S&P +21.5% · vs S&P 500 +25.4% | Jul 22, 2025 | Aug 13, 2025 | 22d |
| Jefferson Shreve | Stock | Sale | $15,001 - $50,000 | +42.2%S&P +51.2% · vs S&P 500 -9.0% | Apr 7, 2025 | May 8, 2025 | 31d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -10.6%S&P +71.4% · vs S&P 500 -82.0% | Jan 20, 2022 | Feb 8, 2022 | 19d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded RGEN?
Lisa C. McClain, Jefferson Shreve, Ro Khanna disclosed RGEN transactions in the filings shown here.
How quickly are RGEN trades disclosed?
Congressional disclosures took a median of 22 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.